CD45RA and R0 isoforms have distinct effects on cytokine- and B-cell-receptor-mediated signalling in human B cells

Scandinavian Journal of Immunology

Volumn 61, Issue 6, 2005, Pages 520-528

  Matto M ^a   Nuutinen, U M ^a   Ropponen, A ^a   Myllykangas, K ^c   Pelkonen, J ^a,b  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

^b KUOPIO UNIVERSITY HOSPITAL   (Finland)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 2 MORPHOLINO 8 PHENYLCHROMONE; B LYMPHOCYTE RECEPTOR; CD45 ANTIGEN; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 13; INTERLEUKIN 15; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 6; ISOPROTEIN; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 3; TUMOR NECROSIS FACTOR ALPHA; LYMPHOCYTE ANTIGEN RECEPTOR;

ARTICLE; B LYMPHOCYTE; B LYMPHOCYTE ACTIVATION; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME PHOSPHORYLATION; FOLLICULAR LYMPHOMA; HUMAN; HUMAN CELL; LYMPHOCYTE ACTIVATION; PRIORITY JOURNAL; PROTEIN ANALYSIS; RECEPTOR BINDING; SIGNAL TRANSDUCTION; T LYMPHOCYTE; CELL DIVISION; COMPARATIVE STUDY; GENETICS; IMMUNOLOGY; METABOLISM; PHYSIOLOGY; POLYMERASE CHAIN REACTION; TUMOR CELL LINE;

ANTIGENS, CD45; B-LYMPHOCYTES; CELL DIVISION; CELL LINE, TUMOR; CYTOKINES; HUMANS; MITOGEN-ACTIVATED PROTEIN KINASE 3; POLYMERASE CHAIN REACTION; RECEPTORS, ANTIGEN, B-CELL; RNA, MESSENGER; SIGNAL TRANSDUCTION;

EID: 21244440265     PISSN: 03009475     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-3083.2005.01624.x     Document Type: Article

References (36)

1. Thomas ML. The leukocyte common antigen family. Annu Rev Immunol 1989;7:339-69.
2. ten Dam GB, Zilch CF, Wallace D et al. Regulation of alternative splicing of CD45 by antagonistic effects of SR protein splicing factors. J Immunol 2000;164:5287-95.
3. Hermiston ML, Xu Z, Weiss A. CD45: a critical regulator of signaling thresholds in immune cells. Annu Rev Immunol 2003;21:107-37.
4. Jensen GS, Poppema S, Mant MJ, Pilarski LM. Transition in CD45 isoform expression during differentiation of normal and abnormal B cells. Int Immunol 1989;1:229-36.
5. Jensen GS, Mant MJ, Belch AJ, Berenson JR, Ruether BA, Pilarski LM. Selective expression of CD45 isoforms defines CALLA+ monoclonal B-lineage cells in peripheral blood from myeloma patients as late stage B cells. Blood 1991;78:711-9.
6. Yu Y, Rabinowitz R, Polliack A, Ben-Bassat H, Schlesinger M. B-lymphocytes in CLL and NHL differ in the mRNA splicing pattern of the CD45 molecule. Eur J Haematol 2000;64:376-84.
7. Yu Y, Rabinowitz R, Polliack A, Ben-Bassat H, Schlesinger M. Hyposialated 185 kDa CD45RA+ molecules attain a high concentration in B lymphoma cells and in activated human B cells. Eur J Haematol 2002;68:22-30.
8. Wienands J, Schweikert J, Wollscheid B, Jumaa H, Nielsen PJ, Reth M. SLP-65: a new signaling component in B lymphocytes which requires expression of the antigen receptor for phosphorylation. J Exp Med 1998;188:791-5.
9. Fu C, Turck CW, Kurosaki T, Chan AC. BLNK: a central linker protein in B cell activation. Immunity 1998;9:93-103.
10. Ishiai M, Kurosaki M, Pappu R et al. BLNK required for coupling Syk to PLC gamma 2 and Rac1-JNK in B cells. Immunity 1999;10:117-25.
11. Benatar T, Carsetti R, Furlonger C, Kamalia N, Mak T, Paige CJ. Immunoglobulin-mediated signal transduction in B cells from CD45-deficient mice. J Exp Med 1996;183:329-34.
12. Pao LI, Bedzyk WD, Persin C, Cambier JC. Molecular targets of CD45 in B cell antigen receptor signal transduction. J Immunol 1997;158:1116-24.
13. Dornan S, Sebestyen Z, Gamble J et al. Differential association of CD45 isoforms with CD4 and CD8 regulates the actions of specific pools of p56lck tyrosine kinase in T cell antigen receptor signal transduction. J Biol Chem 2002;277:1912-8.
14. Shrivastava P, Katagiri T, Ogimoto M, Mizuno K, Yakura H. Dynamic regulation of Src-family kinases by CD45 in B cells. Blood 2004;103:1425-32.
15. Katagiri T, Ogimoto M, Hasegawa K et al. CD45 negatively regulates lyn activity by dephosphorylating both positive and negative regulatory tyrosine residues in immature B cells. J Immunol 1999;163:1321-6.
16. Shirakata Y, Ishii K, Yagita H, Okumura K, Taniguchi M, Takemori T. Distinct subcellular localization and substrate specificity of extracellular signal-regulated kinase in B cells upon stimulation with IgM and CD40. J Immunol 1999;163:6589-97.
17. Healy JI, Dolmetsch RE, Timmerman LA et al. Different nuclear signals are activated by the B cell receptor during positive versus negative signaling. Immunity 1997;6:419-28.
18. Ogimoto M, Arimura Y, Katagiri T et al. Opposing regulation of B cell receptor-induced activation of mitogen-activated protein kinases by CD45. FEBS Lett 2001;490:97-101.
19. Xu Z, Weiss A. Negative regulation of CD45 by differential homodimerization of the alternatively spliced isoforms. Nat Immunol 2002;3:764-71.
20. Greer SF, Lin J, Clarke CH, Justement LB. Major histocompatibility class II-mediated signal transduction is regulated by the protein-tyrosine phosphatase CD45. J Biol Chem 1998;273:11970-9.
21. Greer SF, Justement LB. CD45 regulates tyrosine phosphorylation of CD22 and its association with the protein tyrosine phosphatase SHP-1. J Immunol 1999;162:5278-86.
22. Irie-Sasaki J, Sasaki T, Matsumoto W et al. CD45 is a JAK phosphatase and negatively regulates cytokine receptor signalling. Nature 2001;409:349-54.
23. Li FJ, Tsuyama N, Ishikawa H et al. A rapid translocation of CD45RO but not CD45RA to lipid rafts in IL-6-induced proliferation in myeloma. Blood 2005;105:3295-302.
24. Blank N, Kriegel M, Hieronymus T et al. CD45 tyrosine phosphatase controls common gamma-chain cytokine-mediated STAT and extracellular signal-related kinase phosphorylation in activated human lymphoblasts: inhibition of proliferation without induction of apoptosis. J Immunol 2001;166:6034-40.
25. Yamada T, Zhu D, Saxon A, Zhang K. CD45 controls interleukin-4-mediated IgE class switch recombination in human B cells through its function as a Janus kinase phosphatase. J Biol Chem 2002;277:28830-5.
26. Zhou C, Saxon A, Zhang K. Human activation-induced cytidine deaminase is induced by IL-4 and negatively regulated by CD45: implication of CD45 as a Janus kinase phosphatase in antibody diversification. J Immunol 2003;170:1887-93.
27. Eray M, Postila V, Eeva J et al. Follicular lymphoma cell lines, an in vitro model for antigenic selection and cytokine-mediated growth regulation of germinal centre B cells. Scand J Immunol 2003;57:545-55.
28. Sarnesto A, Ranta S, Seppala IJ, Makela O. Relative immunogenicity in mice of different regions of the human IgG. Scand J Immunol 1983;17:507-11.
29. Kanegane H, Miyawaki T, Kato K et al. A novel subpopulation of CD45RA+ CD4+ T cells expressing IL-2 receptor alpha-chain (CD25) and having a functionally transitional nature into memory cells. Int Immunol 1991;3:1349-56.
30. Richards JD, Dave SH, Chou CH, Mamchak AA, DeFranco AL. Inhibition of the MEK/ERK signaling pathway blocks a subset of B cell responses to antigen. J Immunol 2001;166:3855-64.
31. Fruman DA, Snapper SB, Yballe CM, Davidson L, Yu Y, Alt FW, Cantley LC. Impaired B cell development and proliferation in absence of phosphoinositide 3-kinase p85alpha. Science 1999; 283:393-7.
32. Fruman DA, Ferl GZ, An SS, Donahue AC, Satterthwaite AB, Witte ON. Phosphoinositide 3-kinase and Bruton's tyrosine kinase regulate overlapping sets of genes in B lymphocytes. Proc Natl Acad Sci USA 2002;99:359-64.
33. Gupta N, DeFranco AL. Visualizing lipid raft dynamics and early signaling events during antigen receptor-mediated B-lymphocyte activation. Mol Biol Cell 2003;14:432-44.
34. Cheng PC, Dykstra ML, Mitchell RN, Pierce SK. A role for lipid rafts in B cell antigen receptor signaling and antigen targeting. J Exp Med 1999;190:1549-450.
35. van der Merwe PA, Crocker PR, Vinson M, Barclay AN, Schauer R, Kelm S. Localization of the putative sialic acid-binding site on the immunoglobulin superfamily cell-surface molecule CD22. J Biol Chem 1996;271:9273-80.
36. Bakker TR, Piperi C, Davies EA, Merwe PA. Comparison of CD22 binding to native CD45 and synthetic oligosaccharide. Eur J Immunol 2002;32:1924-32.